Schmidt Hendrik, Müller-Werdan Ursula, Nuding Sebastian, Hoffmann Thomas, Francis Darrel P, Hoyer Dirk, Rauchhaus Mathias, Werdan Karl
University Department of Medicine III, Klinikum Kröllwitz, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06097 Halle/Saale, Germany.
Intensive Care Med. 2004 Apr;30(4):665-72. doi: 10.1007/s00134-003-2131-2. Epub 2004 Feb 12.
The cardiac chemoreflex sensitivity is a powerful predictor of autonomic dysfunction in chronic heart failure and after myocardial infarction. The objective of the present study was to characterize cardiac chemoreflex sensitivity in patients with multiple organ dysfunction syndrome (MODS). We also aimed to elucidate the effect of the severity of MODS on the assessment of cardiac chemoreflex sensitivity.
Prospective cohort study.
Twelve-bed medical intensive care unit in a university center.
Forty consecutively admitted patients with MODS during a 7-month period. Patients with MODS were identified by an APACHE II score of 20 or more. Sepsis was defined as a Sepsis Score, according to Elebute and Stoner, of 12 or more.
The cardiac chemoreflex sensitivity was assessed using the regression of heart interval (ms) versus arterial oxygen pressure (mmHg).
First, we established a new method to assess cardiac chemoreflex sensitivity and applied it to healthy controls and patients. Second, we found that cardiac chemoreflex sensitivity correlated with the severity of MODS as calculated by the APACHE II score ( r(2)=0.34, p=0.001). This relation was best fitted by a model including minimum heart rate and standard bicarbonate in 24 h ( r(2)=0.5, p<0.001) and Glasgow Coma Scale ( r(2)=0.5, p=0.005). Age, however, did not significantly contribute ( r(2)=0.001, p=0.8).
The calculation of cardiac chemoreflex sensitivity enabled us to quantify an important component of the cardiorespiratory interactions in patients with MODS. Severity of illness was a more pronounced determinant of impaired cardiac chemoreflex sensitivity than age. The quantification of the cardiorespiratory interactions by measuring the cardiac chemoreflex sensitivity has potential to identify a subgroup of patients with worse prognosis.
心脏化学反射敏感性是慢性心力衰竭和心肌梗死后自主神经功能障碍的有力预测指标。本研究的目的是描述多器官功能障碍综合征(MODS)患者的心脏化学反射敏感性。我们还旨在阐明MODS严重程度对心脏化学反射敏感性评估的影响。
前瞻性队列研究。
大学中心的一个拥有12张床位的医疗重症监护病房。
在7个月期间连续收治的40例MODS患者。MODS患者通过急性生理学与慢性健康状况评分系统(APACHE II)评分为20分或更高来确定。根据埃勒布特和斯托纳的标准,脓毒症定义为脓毒症评分为12分或更高。
使用心率间期(毫秒)与动脉血氧分压(毫米汞柱)的回归分析来评估心脏化学反射敏感性。
首先,我们建立了一种评估心脏化学反射敏感性的新方法,并将其应用于健康对照者和患者。其次,我们发现心脏化学反射敏感性与通过APACHE II评分计算的MODS严重程度相关(r² = 0.34,p = 0.001)。这种关系通过一个包含最低心率和24小时标准碳酸氢盐(r² = 0.5,p < 0.001)以及格拉斯哥昏迷量表(r² = 0.5,p = 0.005)的模型拟合效果最佳。然而,年龄没有显著影响(r² = 0.001,p = 0.8)。
心脏化学反射敏感性的计算使我们能够量化MODS患者心肺相互作用的一个重要组成部分。疾病严重程度比年龄更能显著决定心脏化学反射敏感性受损。通过测量心脏化学反射敏感性来量化心肺相互作用有可能识别出预后较差的患者亚组。